141 related articles for article (PubMed ID: 12011310)
1. Rapid infusion of intravenous immunoglobulin in patients with neuromuscular diseases.
Gomperts ED; Darr F
Neurology; 2002 May; 58(9):1444. PubMed ID: 12011310
[No Abstract] [Full Text] [Related]
2. Intravenous immune globulin in neuromuscular disorders.
Gupta S
West J Med; 1997 Nov; 167(5):349-50. PubMed ID: 9392991
[No Abstract] [Full Text] [Related]
3. Rapid infusion of intravenous immune globulin in patients with neuromuscular disorders.
Grillo JA; Gorson KC; Ropper AH; Lewis J; Weinstein R
Neurology; 2001 Nov; 57(9):1699-701. PubMed ID: 11706114
[TBL] [Abstract][Full Text] [Related]
4. The use of intravenous immunoglobulins in the treatment of neuromuscular disorders.
Voltz R; Hohlfeld R
Curr Opin Neurol; 1996 Oct; 9(5):360-6. PubMed ID: 8894412
[TBL] [Abstract][Full Text] [Related]
5. Role of intravenous immunoglobulin in the treatment of Kawasaki disease.
Lo MS; Newburger JW
Int J Rheum Dis; 2018 Jan; 21(1):64-69. PubMed ID: 29205910
[TBL] [Abstract][Full Text] [Related]
6. Factors associated with headache in intravenous immunoglobulin treatment for neurological diseases.
Graf J; Ingwersen J; Lepka K; Albrecht P; Hartung HP; Ringelstein M; Aktas O
Acta Neurol Scand; 2019 Oct; 140(4):290-295. PubMed ID: 31269227
[TBL] [Abstract][Full Text] [Related]
7. [Treatment of autoimmune neuromuscular diseases with intravenous immunoglobulins].
Illa I; Serrano C; Prat C
Rev Neurol; 1997 Feb; 25(138):263-6. PubMed ID: 9147754
[No Abstract] [Full Text] [Related]
8. Intravenous gammaglobulin (IVIg) for treatment of CIDP and related immune-mediated neuropathies.
Brannagan TH
Neurology; 2002 Dec; 59(12 Suppl 6):S33-40. PubMed ID: 12499469
[TBL] [Abstract][Full Text] [Related]
9. Developing practice guidelines for the administration of intravenous immunoglobulin.
Murphy E; Martin S; Patterson JV
J Infus Nurs; 2005; 28(4):265-72. PubMed ID: 16106210
[TBL] [Abstract][Full Text] [Related]
10. Safety of intravenous immunoglobulin in the elderly treated for a dysimmune neuromuscular disease.
Lozeron P; Not A; Theaudin M; Denier C; Masnou P; Sarov M; Adam C; Cauquil C; Adams D
Muscle Nerve; 2016 May; 53(5):683-9. PubMed ID: 26467654
[TBL] [Abstract][Full Text] [Related]
11. Practical aspects of immunoglobulin replacement.
Ballow M
Ann Allergy Asthma Immunol; 2017 Oct; 119(4):299-303. PubMed ID: 28958372
[No Abstract] [Full Text] [Related]
12. [Intravenous IgG for treatment of neuromuscular diseases].
Vedeler CA; Mellgren SI; Omdal R; Torbergsen T; Aasly J
Tidsskr Nor Laegeforen; 2010 Sep; 130(17):1717-20. PubMed ID: 20835282
[TBL] [Abstract][Full Text] [Related]
13. Evidence-based guideline: IV immunoglobulin in the treatment of neuromuscular disorders: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.
Li HF; Gao X; Hong Y; Patwa HS; Chaudhry V; Rae-Grant AD; So YT; Alto P
Neurology; 2012 Sep; 79(13):1411; author reply 1411. PubMed ID: 23008223
[No Abstract] [Full Text] [Related]
14. Vesicular and bullous eczema in response to intravenous immunoglobulins (IVIG).
Maetzke J; Sperfeld AD; Scharffetter-Kochanek K; Sunderkötter C
Allergy; 2006 Jan; 61(1):145-6. PubMed ID: 16364173
[No Abstract] [Full Text] [Related]
15. Hemolytic anemia following high dose intravenous immunoglobulin in patients with chronic neurological disorders.
Markvardsen LH; Christiansen I; Harbo T; Jakobsen J
Eur J Neurol; 2014; 21(1):147-52. PubMed ID: 24180709
[TBL] [Abstract][Full Text] [Related]
16. Intravenous immunoglobulin therapy for neuromuscular disorders.
Ross MA
Semin Neurol; 2007 Sep; 27(4):340-6. PubMed ID: 17701871
[TBL] [Abstract][Full Text] [Related]
17. Strokes, thromboembolic events, and IVIg: rare incidents blemish an excellent safety record.
Dalakas MC; Clark WM
Neurology; 2003 Jun; 60(11):1736-7. PubMed ID: 12796522
[No Abstract] [Full Text] [Related]
18. The use of intravenous immunoglobulin in the treatment of autoimmune neuromuscular diseases: evidence-based indications and safety profile.
Dalakas MC
Pharmacol Ther; 2004 Jun; 102(3):177-93. PubMed ID: 15246245
[TBL] [Abstract][Full Text] [Related]
19. The safety profile of home infusion of intravenous immunoglobulin in patients with neuroimmunologic disorders.
Souayah N; Hasan A; Khan HM; Yacoub HA; Jafri M
J Clin Neuromuscul Dis; 2011 Jun; 12 Suppl 4():S1-10. PubMed ID: 22361589
[TBL] [Abstract][Full Text] [Related]
20. Long-term day-case treatment of peripheral neuromuscular disease with intravenous immunoglobulin: the practice of a regional day-case service in Preston, Lancashire.
Nixon J; McHugh C; Jones S
Clin Med (Lond); 2013 Aug; 13(4):358-61. PubMed ID: 23908504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
